Home - Products - Others - Other Targets - Fmoc-Thr(GlcNAc(Ac)3-b-D)-OH

Fmoc-Thr(GlcNAc(Ac)3-b-D)-OH

CAS No. 160168-40-1

Fmoc-Thr(GlcNAc(Ac)3-b-D)-OH( —— )

Catalog No. M21715 CAS No. 160168-40-1

This amino acid is compatible with standard protocols in Fmoc solid phase peptide synthesis. Following chain assembly.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
25MG	276	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Fmoc-Thr(GlcNAc(Ac)3-b-D)-OH
Note

Research use only, not for human use.
Brief Description

This amino acid is compatible with standard protocols in Fmoc solid phase peptide synthesis. Following chain assembly.
Description

This amino acid is compatible with standard protocols in Fmoc solid phase peptide synthesis. Following chain assembly, removal of the acetyl protecting group can be carried out by treatment of the peptidyl resin with methanolic ammonia or sodium methoxide/DMF/methanol, or by treatment of the cleaved peptide with catalytic sodium methoxide in methanol.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

——
Research Area

——
Indication

——

Chemical Information

CAS Number

160168-40-1
Formula Weight

670.66
Molecular Formula

C33H38N2O13
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Alodan

Alodan is an organic chloride insecticide.
KB-74935

KB-74935 is an enzyme inhibitor and a mineralocorticoid receptor antagonist used to treat cholesterol, hypolipidemia, neurological disorders, and Alzheimer's disease.
SB290157 trifluoroac...

SB290157 trifluoroacetate is a potent and selective antagonist of C3a receptor(IC50 of 200 nM). SB 290157 is a competitive antagonist of 125I-C3a radioligand binding to rat basophilic leukemia-2H3 cells expressing the human C3aR (RBL-C3aR, IC50 of 200 nM).

Sign In Join Free